This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.48% per year. These returns cover a period from January 1, 1988 through May 5, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
electric-vehicles: Archive
Is Ferrari Stock Poised to Race Higher?
by Shaun Pruitt
Benefiting from its strong brand and pricing power, Ferrari (RACE) stock is up a respectable +13% in 2025 and is sitting on gains of over +180% in the last three years.
RACEPositive Net Change TSLAPositive Net Change NIOPositive Net Change STLAPositive Net Change
auto-tires-trucks earnings electric-vehicles investing large-cap
Tesla vs. Rivian: What's Currently the Better Buy?
by Derek Lewis
Tesla shares have been big-time winners over the past decade for many, but recent performance has undoubtedly left a sour taste in many mouths. IS it Rivian's time to shine?
TSLAPositive Net Change RIVNNo Net Change
electric-vehicles
Sonic Automotive (SAH)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SAHPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
nLight (LASR) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
LASRNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Vistra Corp. (VST)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
VSTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
EV Roundup: TSLA China Sales Keep Falling, NIO Q1 Loss Widens & More
by Rimmi Singhi
While Tesla's sales in China slump for the eighth straight month in May, NIO's Q1 loss comes wider than estimates as well as from the year-ago period level.
TSLAPositive Net Change NIOPositive Net Change CHPTPositive Net Change LCIDNegative Net Change
electric-vehicles
Rivian to Get $1B from VWAGY Soon: Time to Buy RIVN Stock Now?
by Rimmi Singhi
RIVN hits a key profit milestone, unlocking a fresh $1B from VWAGY by the end of this month as part of a $5.8B joint venture by 2027.
TSLAPositive Net Change VWAGYPositive Net Change RIVNNo Net Change
electric-vehicles
Contango ORE, Inc. (CTGO) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
CTGONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Par Petroleum (PARR) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
PARRPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
NIO Expects Y/Y Rise in Q2 Deliveries: What are the Growth Agents?
by Zacks Equity Research
NIO forecasts June and Q2 deliveries to rise year over year, fueled by fresh model rollouts.
NIOPositive Net Change LINegative Net Change XPEVPositive Net Change
auto-tires-trucks electric-vehicles
Dave Inc. (DAVE) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
DAVENegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Musk-Trump Messy Breakup Wipes Out $150B in TSLA Stock: What's Next?
by Rimmi Singhi
Tesla plunges 14% in a single day as Musk's public feud with Trump threatens subsidies, sales, and robotaxi dreams.
TSLAPositive Net Change GOOGLPositive Net Change BYDDYPositive Net Change
auto-tires-trucks autonomous-vehicles electric-vehicles tech-stocks
Tesla Stock Slumps on Trump-Musk Feud: Buy the Dip in ETFs?
by Sanghamitra Saha
TSLA slipped 14.3% on June 5 due to Musk-Trump tensions, casting doubt on federal support and investor faith. Single-stock ETF TESL lost only1.9% due to downside protection.
TSLAPositive Net Change XLYPositive Net Change NITEPositive Net Change TSLWPositive Net Change TESLPositive Net Change
electric-vehicles etfs
Tesla Stock Falls Amid Musk Vs Trump Feud
by Shaun Pruitt
Tesla (TSLA) shares had their worst day since March, falling 14% on Thursday as the feud between Elon Musk and President Trump continues to heat up.
TSLAPositive Net Change FPositive Net Change GMPositive Net Change XPEVPositive Net Change
auto-tires-trucks earnings electric-vehicles investing large-cap magnificent-7
What's Going on With Tesla Shares?
by Derek Lewis
Tesla shares have found themselves in the spotlight yet again. What's been driving the underperformance in 2025?
TSLAPositive Net Change
electric-vehicles
Hudson Technologies (HDSN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
HDSNPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy SES AI Corporation (SES) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SESNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Tesla's China-Made EV Sales Drop Y/Y in May: Is Price War a Suspect?
by Lavina Shahu
TSLA's China-made EV sales fall for the 8th straight month in May, hit by a fierce price war.
TSLAPositive Net Change GELYYNegative Net Change BYDDYPositive Net Change
auto-tires-trucks electric-vehicles
Cathie Wood Trims TSLA Stake Before Robotaxi Day: Should You Too?
by Rimmi Singhi
Cathie Wood takes profits on Tesla as robotaxi hype peaks ahead of launch. Is this a classic "sell the news" moment, and should you follow her lead?
TSLAPositive Net Change GOOGLPositive Net Change LYFTPositive Net Change UBERNegative Net Change
autonomous-vehicles electric-vehicles ride-hailing self-driving-cars tech-stocks
Carvana Anticipates Margin Improvement: What's Driving the Growth?
by Zacks Equity Research
CVNA posts record adjusted EBITDA in the first quarter of 2025, nearly doubling peers' margins, and expects more gains ahead.
ANPositive Net Change LADPositive Net Change CVNANegative Net Change
auto-tires-trucks electric-vehicles
Will Rivian's Charging Update Help It Catch Up With Rivals?
by Zacks Equity Research
RIVN's latest software update boosts charging speeds, adds manual preconditioning and sharpens energy tracking features.
TSLAPositive Net Change VWAGYPositive Net Change RIVNNo Net Change
auto-tires-trucks electric-vehicles
Tesla Losing Steam in Europe: What's Impeding Its Growth?
by Zacks Equity Research
TSLA sales slid for a fifth straight month in Europe, hit by political backlash, old models and rising competition.
TSLAPositive Net Change VWAGYPositive Net Change BYDDYPositive Net Change
auto-tires-trucks electric-vehicles
Should You Buy Sterling Infrastructure (STRL) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
STRLNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Tesla Robotaxi Nearing Launch: Buy, Hold or Sell the Stock Now?
by Rimmi Singhi
TSLA jumps 23% in the past month on robotaxi hype, but with a few launch details and fading EV sales, is the rally built to last?
TSLAPositive Net Change GOOGLPositive Net Change BYDDYPositive Net Change
artificial-intelligence autonomous-vehicles electric-vehicles
NIO's May Deliveries Rise 13% Y/Y But Is That Good Enough?
by Zacks Equity Research
NIO delivered over 23K EVs in May, but weaker growth and shifting brand dynamics may test its 2025 sales goal.
NIOPositive Net Change LINegative Net Change XPEVPositive Net Change
electric-vehicles